LION Nanoparticles for RNA Delivery and MRI Tracking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
RNA vaccines and therapeutics face challenges in inducing full efficacy and adaptive immune responses, with existing delivery methods lacking efficiency and stability, particularly in protecting RNA from degradation and ensuring effective delivery and imaging within the body.
Innovation Solution
Development of Lipid InOrganic Nanoparticles (LIONs) that form a nanoemulsion composition with a hydrophobic core of liquid oil and inorganic nanoparticles, stabilized by cationic lipids, which complex with RNA to enhance delivery, protect against degradation, and allow for imaging via MRI.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If RNA is delivered using conventional methods or other carrier technologies, then delivery can be achieved, but delivery efficiency is insufficient and RNA is vulnerable to degradation
Solution Approach 1:
The patent employs a composite nanoparticle system combining cationic lipids with inorganic iron oxide cores. This composite structure provides both efficient RNA delivery (through lipid-mediated cellular uptake) and enhanced stability (through inorganic core protection), resolving the contradiction between delivery efficiency and RNA stability. The cationic lipid component enables effective delivery while the iron oxide core provides structural stability and protection against degradation.
Solution Approach 2:
The patent utilizes phase transition properties of lipids at specific temperatures to control RNA release. By formulating nanoparticles with lipids that undergo phase transitions at physiological temperatures, the system achieves stable encapsulation during storage and transport, then efficient release and delivery at injection site temperatures, thereby improving both stability and delivery efficiency simultaneously.
2Reliability
If RNA vaccines are administered to induce immune responses, then therapeutic effect is achieved, but full efficacy and adaptive immune responses are not consistently induced
Solution Approach 1:
The patent introduces inorganic iron oxide nanoparticles as intermediaries that serve dual functions: they act as imaging agents for tracking vaccine delivery and distribution, and as adjuvants that enhance immune response. This intermediary component mediates between the RNA vaccine and the immune system, improving both the reliability of immune response induction and the productivity of adaptive immune responses through enhanced antigen presentation and immune cell activation.
3Productivity
If nanoparticle systems are used for RNA delivery, then delivery efficiency improves, but imaging and tracking capabilities are lost
Solution Approach 1:
The patent merges two previously separate functions into a single integrated nanoparticle system: RNA delivery (through cationic lipid formulation) and imaging/tracking (through inorganic iron oxide core). This merging allows the same nanoparticle to simultaneously achieve efficient RNA delivery and provide MRI-compatible imaging capabilities, eliminating the trade-off between delivery efficiency and detectability.
Solution Approach 2:
The iron oxide-containing nanoparticle is designed with multi-functionality, serving as both a delivery vehicle for RNA and an imaging agent for tracking. This universal platform simultaneously performs therapeutic delivery and diagnostic imaging functions, resolving the contradiction by making the delivery system itself detectable without requiring separate imaging components.
4Difficulty of detecting and measuring
If inorganic nanoparticles are incorporated into the delivery system, then imaging capability is achieved, but particle complexity increases
Solution Approach 1:
The patent employs a nested structure where the inorganic iron oxide core is embedded within the cationic lipid shell. This nested architecture allows the simpler iron oxide core to provide imaging functionality while the lipid shell provides biocompatibility and RNA binding, achieving imaging capability without significantly increasing overall system complexity. The nested design integrates multiple functions in a hierarchical manner that minimizes structural complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
LIONs significantly improve RNA delivery efficiency, protect RNA from degradation, and induce robust immune responses, including neutralizing antibodies, while enabling tracking within the body through imaging capabilities.
Implementation Method 1
the nanoparticles contain a cationic lipid that stabilizes the RNA and protects it from degradation
Implementation Method 2
the nanoparticles have a reporter element allowing for imaging and tracking the particles in the body
Data Source
AI summary
The disclosure provides nanoemulsion compositions and methods of making and using thereof to deliver a bioactive agent such as a nucleic acid to a subject. The nanoemulsion composition comprises a hydrophobic core based on inorganic nanoparticles in a lipid nanoparticle that allows imaging as well as delivering nucleic acids. Methods of using these particles for treatment and vaccination are also provided.